Bleeding and thrombotic risk in LAA closure patients

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: C. Allen, W. Wojakowski

Speakers: T. Lyngby, N. Ammirabile, L. R. Carmen, M. A. Montilla, K. Zielinski, N. Pyrpyris

Summary

This session provides a thorough examination of bleeding and thrombotic risks in patients undergoing left atrial appendage (LAA) closure. It reviews risk factors for device-related thrombosis, compares anticoagulation strategies post-procedure, and presents real-world clinical outcomes, particularly in high bleeding risk populations and special groups such as cancer patients.

Presentations available when logged in:

Risk factors for device-related thrombosis after left atrial appendage closure
Direct oral anticoagulant monotherapy vs. dual antiplatelet therapy after LAA closure
Closing the appendage, improving outcomes? Real-world insights from a LAA Closure
Outcomes of LAA closure in high bleeding risk patients: real-world experience
Hybrid of LAA closure and anticoagulation after anticoagulation failure
In-hospital outcomes of patients with cancer diagnosis undergoing LAA occlusion

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Bleeding and thrombotic risk in LAA closure patients

Session comprising selected EuroPCR 2026 abstract submissions

Log in or create account for free